ReviewPostepy dermatologii i alergologii2024

The IL-23/Th17 pathway inhibitors in the treatment of psoriasis and the risk of skin malignancies: a review.

Marta Krzysztofik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.